← Leaderboards
Belen Pascual
Methodist Hospital Research Institute
$973,959
Attributed
$1,947,918
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $651.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,947,918 · 1
By mechanism
R01$1,947,918 · 1
Top collaborators
- Alireza Faridar3 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Shu-Hsia Chen$16,255,143
- Rose Khavari$1,836,329
- Alireza Faridar$1,227,361
- Stephen Tc Wong$23,111,474
- Tony Y. Hu$10,601,361
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAmyloid Beta-42Clinical ResearchAnti-Inflammatory AgentsAstrocytesBiological MarkersBloodBrainBrain ImagingCellsCentral Nervous SystemCerebrospinal FluidChemokineChronicAnimal ModelClinical TrialsCognitionCytokineDisease ProgressionDoseDouble-Blind MethodEfficacy TrialEncephalitisAmyloid
Grant awards (3)
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$644,840
R01 · FY2025 · AG
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$651,539
R01 · FY2024 · AG
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy$651,539
R01 · FY2023 · AG